A Phase II Clinical Study of SHR-A1904 Monotherapy in Second-Line or Later Treatment of Advanced Neuroendocrine Carcinoma
Clinical trial NCT07520357 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07520357
- Sponsor
- Beijing GoBroad Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-30
- Primary completion
- 2028-02-28
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.